Zobrazeno 1 - 10
of 7 735
pro vyhledávání: '"Autosomal Dominant Polycystic Kidney Disease"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract This retrospective study investigated the incidence, medication use, and outcomes in pediatric autosomal-dominant polycystic kidney disease (ADPKD) using Taiwan's National Health Insurance Research Database (NHIRD). A 1:4 matched control gro
Externí odkaz:
https://doaj.org/article/4c17ec6ae8e74c508b73c4cd9636d9d1
Autor:
Liliana Italia De Rosa, Martina Catania, Francesca Tunesi, Marta Vespa, Romina Bucci, Kristiana Kola, Giuseppe Vezzoli, Maria Teresa Sciarrone Alibrandi
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 14, Iss 1, Pp 116-121 (2024)
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disease and the 4th leading cause of renal replacement therapy in the world. ADPKD is a systemic disorder as cysts may develop in several organs. Liv
Externí odkaz:
https://doaj.org/article/377331f6c1344cb5b74345e91fce0f8c
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 14, Iss 1, Pp 104-109 (2024)
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease, which is mainly caused by pathogenic variants in two particular genes: PKD1 and PKD2. ADPKD caused by variants in other genes (GANAB or I
Externí odkaz:
https://doaj.org/article/1e348d8228474ea885b6928b6d0fa88b
Publikováno v:
Zeitschrift für Medizinische Physik, Vol 34, Iss 2, Pp 330-342 (2024)
An accurate prognosis of renal function decline in Autosomal Dominant Polycystic Kidney Disease (ADPKD) is crucial for early intervention. Current biomarkers used are height-adjusted total kidney volume (HtTKV), estimated glomerular filtration rate (
Externí odkaz:
https://doaj.org/article/e2beb9d4004049fc8e788818a1a8d872
Publikováno v:
Journal of Medical Ultrasound, Vol 32, Iss 2, Pp 110-115 (2024)
With an estimated prevalence of 1 in 1000 individuals globally, autosomal dominant polycystic kidney disease (ADPKD) stands as the most prevalent inherited renal disorder. Ultrasonography (US) is the most widely used imaging modality in the diagnosis
Externí odkaz:
https://doaj.org/article/31cd0a1f7c6242c98f55f7c11dca41fd
Autor:
Deirdre Mladsi, Xiaolei Zhou, Gregory Mader, Myrlene Sanon, Jinyi Wang, Christine Barnett, Cynthia Willey, Stephen Seliger
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Autosomal dominant polycystic kidney disease (ADPKD) is the leading inheritable cause of end-stage renal disease (ESRD). Mortality data specific to patients with ADPKD is currently lacking; thus, the aim of this study was to estim
Externí odkaz:
https://doaj.org/article/55d13edbf29f4d5ca848338e68ba97f0
Autor:
Philip W. Brownjohn, Azedine Zoufir, Daniel J. O’Donovan, Saatviga Sudhahar, Alexander Syme, Rosemary Huckvale, John R. Porter, Hester Bange, Jane Brennan, Neil T. Thompson
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Autosomal dominant polycystic kidney disease (ADPKD) is a rare genetic disorder characterised by numerous renal cysts, the progressive expansion of which can impact kidney function and lead eventually to renal failure. Tolvaptan is the only disease-m
Externí odkaz:
https://doaj.org/article/f0f14632f7bf4fa7be3e8e7254e4258c
Publikováno v:
Frontiers in Molecular Biosciences, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/b01236b97bd0401bab9efc29bce9e0ec
Autor:
Elise Hoover, Vanessa Holliday, Nicole Merullo, Dorothee Oberdhan, Ronald D. Perrone, Chris Rusconi, Meyeon Park, Milind A. Phadnis, Nadeesha Thewarapperuma, Neera K. Dahl
Publikováno v:
Kidney Medicine, Vol 6, Iss 5, Pp 100813- (2024)
Rationale & Objective: Autosomal dominant polycystic kidney disease (ADPKD) affects health-related quality of life (HRQoL) including pain, discomfort, fatigue, emotional distress, and impaired mobility. Stakeholders prioritized kidney cyst-related pa
Externí odkaz:
https://doaj.org/article/f4ea332d6b3a4a40bb39c6bd2ec097f8
Publikováno v:
Kidney Medicine, Vol 6, Iss 5, Pp 100815- (2024)
Alport syndrome (AS) is a progressive hereditary kidney disease characterized by hematuria, proteinuria, and progressive kidney dysfunction accompanied by sensorineural hearing loss and ocular abnormalities. Pathogenic COL4A3-5 variants can result in
Externí odkaz:
https://doaj.org/article/9b76a6ee187e42edb3314fdfc9715e6f